Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[21] The clinical significance of aldosterone synthase deficiency: report of a novel mutation in the CYP11B2 gene
Hui, Elaine
Yeung, Matthew C. W.
Cheung, Pik To
Kwan, Elaine
Low, Louis
Tan, Kathryn C. B.
Lam, Karen S. L.
Chan, Angel O. K.
BMC ENDOCRINE DISORDERS, 2014, 14
[22] Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors
LaSala, Daniel
Shibanaka, Yasuhiko
Jeng, Arco Y.
ANALYTICAL BIOCHEMISTRY, 2009, 394 (01) : 56 - 61
[23] A case of primary selective hypoaldosteronism carrying three mutations in the aldosterone synthase (Cyp11b2) gene
Taranta, Anna
Bizzarri, Carla
Masotti, Andrea
Scire, Giuseppe
Pampanini, Valentina
Cappa, Marco
GENE, 2012, 500 (01) : 22 - 27
[24] Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency
Tippayakarn Klomchan
Vichit Supornsilchai
Suttipong Wacharasindhu
Vorasuk Shotelersuk
Taninee Sahakitrungruang
European Journal of Pediatrics, 2012, 171 : 1559 - 1562
[25] Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency
Klomchan, Tippayakarn
Supornsilchai, Vichit
Wacharasindhu, Suttipong
Shotelersuk, Vorasuk
Sahakitrungruang, Taninee
EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (10) : 1559 - 1562
[26] Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene
Kayes-Wandover, KM
Tannin, GM
Shulman, D
Peled, D
Jones, KL
Karaviti, L
White, PC
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11): : 5379 - 5382
[27] Polymorphic variation in the aldosterone synthase gene (CYP11B2) in aldosterone-producing adenomas
Inglis, G
Plouin, P
Friel, E
Davies, E
Fraser, R
Connell, J
JOURNAL OF HYPERTENSION, 2000, 18 : S75 - S75
[28] The aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) genes are not expressed in the rat heart
Ye, P
Kenyon, CJ
MacKenzie, SM
Jong, AS
Miller, C
Gray, GA
Wallace, A
Ryding, AS
Mullins, JJ
McBride, MW
Graham, D
Fraser, R
Connell, JMC
Davies, E
ENDOCRINOLOGY, 2005, 146 (12) : 5287 - 5293
[29] Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
Takeda, Yoshimichi
Demura, Masashi
Kometani, Mitsuhiro
Karashima, Shigehiro
Yoneda, Takashi
Takeda, Yoshiyu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
[30] Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
Bogman, Katrijn
Schwab, Dietmar
Delporte, Marie-Laure
Palermo, Giuseppe
Amrein, Kurt
Mohr, Susanne
Mudry, Maria Cristina De Vera
Brown, Morris J.
Ferber, Philippe
HYPERTENSION, 2017, 69 (01) : 189 - 196

← 1 2 3 4 5 →